<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00747565</url>
  </required_header>
  <id_info>
    <org_study_id>DIOL-104-TCNS &amp; DIOL-101-TCNS</org_study_id>
    <nct_id>NCT00747565</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of a Multifocal Intraocular Lens (IOL)</brief_title>
  <official_title>Clinical Evaluation of the Tecnis Multifocal Intraocular Lens (IOL), Model ZM900, Original Study (DIOL-101-TCNS); Clinical Evaluation of the Tecnis Multifocal Intraocular Lens, Model ZM900, Expansion Study (DIOL-104-TCNS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Optics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Optics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and effectiveness of the ZM900 Tecnis Multifocal lens. Results from
      two studies (an original study with 125 multifocal and 123 monofocal subjects, protocol
      DIOL-101-TCNS, and an expansion study with 222 additional multifocal subjects, protocol
      DIOL-104-TCNS) are combined to evaluate the ZM900 Tecnis Multifocal lens vs. a monofocal
      control. The original study was conducted in 2004-2006; the expansion study was conducted in
      2007-2008. Results from both studies were analyzed together for FDA approval.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The original study was protocol DIOL-101-TCNS; the expansion study was protocol
      DIOL-104-TCNS. The study protocols were almost identical with the exception that no control
      subjects were enrolled in the expansion study; only additional multifocal subjects. All
      eligibility criteria and testing conducted in the expansion study was the same as that in the
      original study. The hypotheses were that best corrected distance visual acuity of the ZM900
      lens would meet or exceed the FDA grid values, complication and adverse event rates of the
      ZM900 would be similar to the FDA grid rates for posterior chamber IOLs, and near visual
      acuity of the ZM900 lens would be improved compared to that of the monofocal control lens.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2004</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants That Achieved Best Corrected Distance Visual Acuity of 20/40 or Better in the First Eye.</measure>
    <time_frame>One year</time_frame>
    <description>Number of participants that achieved a best corrected distance visual acuity of 20/40 or better in the first eye. As most subjects were implanted bilaterally,&quot;first eye&quot; refers to the first implanted eye of each subject.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Binocular Distance Corrected Near Visual Acuity in Snellen</measure>
    <time_frame>One year</time_frame>
    <description>Mean binocular near visual acuity with distance correction in place measured at 33 cm; Mean is reported in Snellen (e.g. 20/20, 20/40, etc.), standard deviation reported in ETDRS (Early treatment diabetic retinopathy study)eye chart log units.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">470</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Tecnis Multifocal IOL group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects implanted bilaterally with the Tecnis Multifocal IOL. Participants were enrolled in this arm in the original study and also in the expansion study. Outcomes of the first eye of each subject were analyzed for the primary study endpoints.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CeeOn 911A monofocal control IOL group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects implanted bilaterally with the CeeOn 911A monofocal IOL. Participants enrolled in this arm only in the original study; no control subjects were enrolled in the expansion study. Outcomes of the first eye of each subject were analyzed for the primary study endpoints.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tecnis ZM900 Multifocal Intraocular Lens</intervention_name>
    <description>Investigational intraocular lens</description>
    <arm_group_label>Tecnis Multifocal IOL group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CeeOn 911A monofocal IOL</intervention_name>
    <description>Monofocal Control IOL</description>
    <arm_group_label>CeeOn 911A monofocal control IOL group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Visual potential of 20/30 or better in each study eye

          -  Preoperative BCDVA worse than Snellen 20/40 or worse than 20/30 in the presence of
             glare (as measured using a Snellen chart with BAT at medium)

          -  Naturally dilated pupil size (in dim light) &gt; 4.0 mm (with no dilation medications)
             for each study eye

          -  Preoperative corneal astigmatism of 1.0 D or less

        Exclusion Criteria:

          -  Use of systemic or ocular medications that may affect vision (the use of any miotic
             agent is specifically contraindicated)

          -  Acute or chronic disease or illness that would increase the operative risk or confound
             the study outcome(s),(e.g., diabetes mellitus, immunocompromised, connective tissue
             disease, etc.)

          -  Uncontrolled systemic or ocular disease

          -  History of ocular trauma or prior ocular surgery or subjects expected to require
             retinal laser treatment or other surgical intervention

          -  Presence of ocular pathology other than cataract such as:

               -  Amblyopia or strabismus

               -  Corneal abnormalities

               -  Pupil abnormalities

               -  Capsule or zonule abnormalities

               -  Intraocular inflammation

               -  Known pathology that may affect visual acuity and/or are predicted to cause
                  future acuity losses to a level of 20/30 or worse (e.g. macular degeneration)

          -  Requiring an intraocular lens outside the study diopter range

          -  Contact lens usage prior to study procedure (time interval dependent upon contact lens
             type)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Packer, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Drs. Fine, Hoffman and Packer</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2008</study_first_submitted>
  <study_first_submitted_qc>September 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2008</study_first_posted>
  <results_first_submitted>August 14, 2009</results_first_submitted>
  <results_first_submitted_qc>November 30, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 2, 2010</results_first_posted>
  <last_update_submitted>February 27, 2013</last_update_submitted>
  <last_update_submitted_qc>February 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cataract, tecnis, multifocal, intraocular lens</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Multifocal and monofocal control subjects were enrolled in the original study in 2004-2005 from the normal cataract populations at 13 USA sites. In the expansion study, additional multifocal subjects were enrolled from the normal cataract populations at 16 USA sites (13 who also participated in the original study) in 2007.</recruitment_details>
      <pre_assignment_details>Subjects chose which type of lens to receive (multifocal or monofocal) in the original study. Subjects only received the multifocal lens in the expansion study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Tecnis Multifocal Subjects</title>
          <description>Note: only outcomes of the first eye implanted of each Tecnis Multifocal subject were analyzed for primary endpoints.</description>
        </group>
        <group group_id="P2">
          <title>Monofocal Control Subjects</title>
          <description>Note: Only outcomes of the first eye implanted of each monofocal control subject were analyzed for primary endpoints.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="347">125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.</participants>
                <participants group_id="P2" count="123"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="333">118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.</participants>
                <participants group_id="P2" count="116"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Tecnis Multifocal Subjects</title>
          <description>Note: only outcomes of the first eye implanted of each Tecnis Multifocal subject were analyzed for primary endpoints.</description>
        </group>
        <group group_id="B2">
          <title>Monofocal Control Subjects</title>
          <description>Note: Only outcomes of the first eye implanted of each monofocal control subject were analyzed for primary endpoints.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="347"/>
            <count group_id="B2" value="123"/>
            <count group_id="B3" value="470"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="144"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="203"/>
                    <measurement group_id="B2" value="96"/>
                    <measurement group_id="B3" value="299"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.9" spread="9.5"/>
                    <measurement group_id="B2" value="68.7" spread="8.9"/>
                    <measurement group_id="B3" value="66.7" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="211"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="292"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="136"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="347"/>
                    <measurement group_id="B2" value="123"/>
                    <measurement group_id="B3" value="470"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants That Achieved Best Corrected Distance Visual Acuity of 20/40 or Better in the First Eye.</title>
        <description>Number of participants that achieved a best corrected distance visual acuity of 20/40 or better in the first eye. As most subjects were implanted bilaterally,&quot;first eye&quot; refers to the first implanted eye of each subject.</description>
        <time_frame>One year</time_frame>
        <population>First eye results from subjects at one year in both the original study and the expansion study combined.</population>
        <group_list>
          <group group_id="O1">
            <title>Tecnis Multifocal Subjects</title>
            <description>Note: only outcomes of the first eye implanted of each Tecnis Multifocal subject were analyzed for primary endpoints.</description>
          </group>
          <group group_id="O2">
            <title>Monofocal Control Subjects</title>
            <description>Note: Only outcomes of the first eye implanted of each monofocal control subject were analyzed for primary endpoints.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants That Achieved Best Corrected Distance Visual Acuity of 20/40 or Better in the First Eye.</title>
          <description>Number of participants that achieved a best corrected distance visual acuity of 20/40 or better in the first eye. As most subjects were implanted bilaterally,&quot;first eye&quot; refers to the first implanted eye of each subject.</description>
          <population>First eye results from subjects at one year in both the original study and the expansion study combined.</population>
          <units>Participants (First Eyes only)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="331"/>
                <count group_id="O2" value="114"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="329"/>
                    <measurement group_id="O2" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Binocular Distance Corrected Near Visual Acuity in Snellen</title>
        <description>Mean binocular near visual acuity with distance correction in place measured at 33 cm; Mean is reported in Snellen (e.g. 20/20, 20/40, etc.), standard deviation reported in ETDRS (Early treatment diabetic retinopathy study)eye chart log units.</description>
        <time_frame>One year</time_frame>
        <population>Binocular subjects at one year available for testing for both studies combined.</population>
        <group_list>
          <group group_id="O1">
            <title>Tecnis Multifocal Subjects</title>
            <description>Note: only outcomes of the first eye implanted of each Tecnis Multifocal subject were analyzed for primary endpoints.</description>
          </group>
          <group group_id="O2">
            <title>Monofocal Control Subjects</title>
            <description>Note: Only outcomes of the first eye implanted of each monofocal control subject were analyzed for primary endpoints.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Binocular Distance Corrected Near Visual Acuity in Snellen</title>
          <description>Mean binocular near visual acuity with distance correction in place measured at 33 cm; Mean is reported in Snellen (e.g. 20/20, 20/40, etc.), standard deviation reported in ETDRS (Early treatment diabetic retinopathy study)eye chart log units.</description>
          <population>Binocular subjects at one year available for testing for both studies combined.</population>
          <units>Mean Snellen Line (with ETDRS line SD)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="291"/>
                <count group_id="O2" value="113"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24" spread="1.09"/>
                    <measurement group_id="O2" value="70" spread="1.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ETDRS line scores used for statistical comparisons with mean Snellen values reported above.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Tecnis Multifocal Subjects</title>
          <description>Note: only outcomes of the first eye implanted of each Tecnis Multifocal subject were analyzed for primary endpoints. One additional multifocal subject was enrolled but received an incorrect lens; this subject is included for adverse event reporting for a total of 348 (347 +1) multifocal subjects.</description>
        </group>
        <group group_id="E2">
          <title>Monofocal Control Subjects</title>
          <description>Note: Only outcomes of the first eye implanted of each monofocal control subject were analyzed for primary endpoints.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="348"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="123"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Endophthalmitis, hypopyon and surgical intervention</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="5" subjects_affected="1" subjects_at_risk="348"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="123"/>
              </event>
              <event>
                <sub_title>Signifcant loss in vision due to stroke</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="123"/>
              </event>
              <event>
                <sub_title>Lens-related lens removal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="123"/>
              </event>
              <event>
                <sub_title>Lens-related other surgical procedures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="348"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="123"/>
              </event>
              <event>
                <sub_title>Non-lens-related lens exchange</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="348"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="123"/>
              </event>
              <event>
                <sub_title>Non-lens-related other surgical procedures</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="348"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="123"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="348"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="123"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PIs may not publish or disclose study data without Sponsor's prior written approval.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Results from the original study (DIOL-101-TCNS) and the expansion study (DIOL-104-TCNS) were analyzed together. The original study enrolled both multifocal and monofocal control subjects; the expansion study enrolled additional multifocal subjects.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Nicholas Tarantino, O.D., Head, Global Clinical Research &amp; Development</name_or_title>
      <organization>Abbott Medical Optics, Inc.</organization>
      <phone>866-427-8477 ext 8613</phone>
      <email>nicholas.tarantino@amo.abbott.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

